ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The U.K. will create a $75 million center of excellence for small-molecule pharmaceutical and fine chemicals manufacturing near Glasgow, Scotland. The center aims to help industry, academia, health care providers, and regulators address challenges in the medicine supply chain. Users will be able to evaluate processes using continuous, autonomous, and digital technologies. Creation of the center, which will generate up to 80 jobs, will begin this summer and continue for three years. It’s backed by a consortium featuring the University of Strathclyde, AstraZeneca, and GlaxoSmithKline.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter